Like patients with HIT, patients with VITT present with thrombocytopenia (low platelets) and thrombosis (blood clots, often at unusual sites) and have an anti-platelet factor 4 (PF4) antibody which induces platelet activation4. This evidence concerns the gene PF4 and Thrombocytopenia.